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1. Introduction
Vitiligo is a chronic acquired hypomelanotic disorder affecting
0.5–2% of the world’s population, without any racial, sexual or
regional differences in prevalence [1,2].
This disease is characterised by the loss of melanocytes in the
epidermis (and probably in other organs). The selective destruction
of skin melanocytes results in the development of white patches
often surrounded by hyperpigmented skin. These patches, which
are initially small, progressively increase in size and tend to form
larger patches. These patches can break out in virtually any part of
the body although the face, the back of the hands, wrists, axillae,
umbilicus and genitalia are the regions that aremost often affected
[3,4].
Several types of vitiligo have been described, according to the
distribution of the achromic lesions. One or more lesions in a
dermatomal pattern are characteristic of segmental vitiligo while
this segmental distribution is absent in focal vitiligo. Both are
localised types of vitiligo. Generalized vitiligo is characterised by
the symmetrical distribution of multiple scattered lesions [5,6].
In contrast to the ease of clinical diagnosis, the cellular
mechanisms and biochemical changes leading to the appearance
of the achromic lesions are still uncertain.
There are three major pathogenetic hypotheses. The auto-
immune theory proposes that melanocytes are killed by an
immune-mediatedmechanism, involving either cytotoxicmemory
T cells or autoantibodies directed against melanocyte-surface
antigens, as a result of a breakdown in tolerance [7]. This
hypothesis is supported by the frequent association of vitiligo
with autoimmune diseases, such as autoimmune thyroiditis,
diabetes mellitus, pernicious anemia and alopecia areata, and by
the effectiveness of immunomodulatory agents, such as corticos-
teroids and calcineurin inhibitors, in the treatment of vitiligo [8].
The biochemical hypothesis states that the autocytotoxic
metabolites of melanin synthesis are responsible for the destruc-
tion of melanocytes [9]. Furthermore, several studies suggest that
the possible damage brought about by increased intracellular
oxidative stress would lead to the functional impairment of
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A B S T R A C T
Background: Vitiligo is a chronic acquired hypomelanotic disorder affecting 0.5–2% of the world’s
population. The two major pathogenetic hypotheses are focused on immune-mediated or toxic-
mediated cell damage primarily directed at melanocytes. Recent experimental data underline the
complex interactions that exist between melanocytes and other cells found in the skin.
Objective: Among these cells, keratinocytes are able to influence both the survival and the functional
activity of melanocytes. In order to gain insights into the involvement of different types of epidermic
cells in the pathogenesis of vitiligo, we have performed an ultrastructural study on lesional, perilesional
and normal skin from 12 patients. All these patients suffered from non-segmental vitiligo, with a similar
clinical history in terms of lesion extension and duration of the disease.
Methods: We have therefore grown cultures of keratinocytes from lesional, perilesional and healthy
skin, evaluating the presence of oxidative damage and apoptotic markers in the cells.
Results: Taken together, our results indicate that keratinocytes from perilesional skin show features of
damaged cells.
Conclusion: Our data, besides considering the achromic patch as the terminal event of a chain of
biological processes that take place in the perilesional skin, highlight keratinocytes as having an
important role in the development of vitiligo.
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melanocytes [10]. Increased levels of pro-oxidants, as well as
decreased levels of anti-oxidant agents, have been found in the
blood of patients suffering from vitiligo [11]. Moreover, other
studies indicate the presence of oxidative stress-induced damage
within the epidermis of vitiliginous lesions [12].
Segmental vitiligo is best explained by the neural theory.
According to this hypothesis, some chemical mediators released
from peripheral nerve endings cause decreased melanin produc-
tion [13,14].
Patients affected by vitiligo show an enhanced production of
GTP-cyclohydrolase I leading to an excessive de novo synthesis of
(6R)5,6,7,8 tetrahydrobiopterin (6-BH-4). Continuous production
of 6-BH-4 leads to increased synthesis of the catecholamines in
keratinocytes, leading to an excess of norepinephrine in both the
plasma and urine of these patients [15,16]. In addition to a direct
cytotoxic effect, catecholaminemetabolites could exert an indirect
action through the activation of the a-adrenergic receptors of skin
arterioles, eventually leading to vasoconstriction. Severe or
repeated attacks of hypoxia cause toxic oxygen radicals to
accumulate, resulting in depigmentation [17]. Recent studies have
reported ultrastructural evidence of axonal damage in the nerves
of segmental vitiliginous lesions, which supports this hypothesis
[18].
According to all these pathogenetic mechanisms, vitiligo can be
viewed as an event that only affects, whether primarily or
secondarily, melanocytic cells. None of them takes into account
the interactions of melanocytes with other epidermal or dermal
cells, which are able to influence both the functional activity and
the survival of melanocytes. Recent experimental data underlines
the complex interactions that exist between melanocytes and
other cutaneous cells, such as keratinocytes, Langerhans cells,
endothelial cells, fibroblasts and mast cells [19–23].
This data supports the concept of the epidermal melanic unit
proposed by Fitzpatrick and Breathnach [24], as it highlights the
central role that melanocytes play in receiving the stimulating
and/or inhibitory signals produced by keratinocytes, mast cells,
fibroblasts, lymphocytes, macrophages, and nerve endings. An
alteration of the microenvironment, which is composed of
cytokines and growth factors, may lead to melanocyte dysfunc-
tion, as a result of its early apoptotic death. Therefore,
vitiliginous achromic lesions may be the result of altered
signaling, which is characterised by a dominant inhibiting effect.
According to this relatively new etiopathogenetic mechanism –
the so-called ‘‘eclectic hypothesis’’ [25] – vitiligo is the
expression of a change in the normal communication network,
involving melanocytes, keratinocytes, mast cells and fibroblasts,
which results in a biochemical imbalance (related to growth
factors, cytokines, inflammatory mediators and adhesion mole-
cules) that does not permit melanocytic survival in the epidermal
environment. The creation of an adverse microenvironment
would induce the early death of melanocytes by apoptosis and
the formation of achromic lesions. These become permanent
because healthy melanocytes and reservoir cells are unable to
colonise such areas [26,27].
Previously published data on the ultrastructural features of
lesional, perilesional and normal skin from patients that have
vitiligo is conflicting. This is mainly due to the fact that skin
samples are often collected at different stages in the course of the
disease [28–32]. In order to clarify these discrepancies, we have
performed an ultrastructural study of lesional, perilesional and
normal skin from 12 patients with non-segmental vitiligo, all of
which had a similar clinical historywith respect to lesion extension
and duration of the disease. In our study, lesional, perilesional and
healthy skin is defined as clinically affected skin (lesional), skin
along the edge of the white patch (perilesional) and clinically
unaffected, normally pigmented skin (healthy). We have therefore
grown keratinocytes cultures from lesional, perilesional and
healthy skin to evaluate the presence of oxidative damage and
apoptotic markers in the cells.
2. Materials and methods
Punch-biopsies of 6 mm were taken from lesional, perilesional
and healthy skin of 12 patients affected by non-segmental vitiligo.
The clinical information of each patient is summarised in Table 1.
Written permission was obtained from all patients. Procedures
were carried out in accordance with the ethical standards of the
Committees on Human Experimentation of the Dipartimento di
Scienze Morfologiche. The study was conducted in accordance
with the Declaration of Helsinki.
2.1. Keratinocyte isolation and culture
Each single biopsy (from lesional, perilesional and healthy skin)
from each patient was cut into two pieces: one half was prepared
for cell culture and the other half – which was further divided into
two – for conventional microscopy and for electron microscopy.
2.2. Cell culture
The fat and the subcutis was removed from the small skin
specimen (from lesional, perilesional and healthy skin of each
Table 1
Clinical data of vitiligo patients.
Patients Age Clinical type of vitiligo Age of onset Biopsy site (lesional and perilesional skin)a Biopsy site (healthy skin)a
Mb1 43 NSc generalized 19 Trunk Abdomen
M2 51 NS generalized 6 Trunk Abdomen
M3 47 NS generalized 11 Abdomen Trunk
M4 39 NS generalized 5 Pubis Abdomen
M5 52 NS generalized 25 Abdomen Trunk
M6 45 NS localised 21 Trunk Abdomen
Fd1 44 NS generalized 31 Abdomen Trunk
F2 38 NS generalized 20 Trunk Abdomen
F3 49 NS generalized 13 Trunk Abdomen
F4 42 NS generalized 33 Pubis Abdomen
F5 50 NS generalized 27 Abdomen Trunk
F6 46 NS localised 18 Trunk Abdomen
a Vitiligo was considered to be stable, as no new lesions or enlargement of old lesions occurred in the last 3 years.
b Male.
c Non-segmental vitiligo.
d Female.
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patient) through the use of surgical scissors and washed several
times in a buffered saline solution (PBS), to which antibiotics and
antimycotics were also added. Each piece was further cut into
many tiny pieces. The first enzymatic digestion was performed
with collagenase (Sigma, Milan, Italy), for 3 h at 37 8C in a 5% CO2
humidified atmosphere, in RPMI 1640 medium with 1% penicillin/
streptomycin (Sigma–Adrich,Milan, Italy). Themedium containing
the cells was then centrifuged and the supernatant was discarded.
A second enzymatic digestion was then performed with Trypsin/
EDTA for 2 h at 37 8C in a 5% CO2 humidified atmosphere. The
enzymatic digestion was stopped using a Trypsin Neutralising
Solution (Cambrex, Italy) and EDTA. The cells were then washed
three times and finally put in KGM-2 BulletKit (Cambrex, Italy)
until they reached confluence. When the cells reached confluence,
they were cut and, after an internal immunostaining control with
pancytokeratin-antibody (Sigma, Milan, Italy), further cultivated
for many consecutive passages in KGM-2 BulletKit.
2.3. Immunofluorescence
The expression of cytokeratines was evaluated at each passage
in vitro by a positive staining to pan-cytokeratin-antibody (Fig. 1)
in order to assess themaintenance of the same immunophenotype.
At the first passage, the absence of vimentin expression induced us
to exclude the presence of any fibroblasts.
2.4. Electron microscopy
A quarter of each skin biopsy (of lesional, perilesional and
healthy skin) was fixed in a mixture of 2% formaldehyde and 2.5%
gluteraldehyde in 0.1 mmol/l cacodylate buffer, pH 7.4, at 5 8C for
3 h, followed by postfixation in 1% OsO4 in phosphate buffer, pH
7.4, at room temperature for 2 h. The specimens were dehydrated
in a graded acetone series, passed through propylene-oxide and
embedded in epon 812. A sequential number of semithin sections
were coloured with toluidine blue, while ultrathin sections were
stained with uranyl acetate, followed by bismuth subnitrate or
lead citrate, and examined in a Jeol 1010 (Tokyo, Japan) at 80 kV.
2.5. Preparation of cell homogenates
Keratinocytes (1  106) were washed twice with phosphate
buffer saline (PBS), trypsinised, centrifuged and then resuspended
in 100mL of Lysis buffer containing 1% Triton X-100, 20 mM Tris–
HCl pH8, 137 mM NaCl, 10% (v/v) Glycerol, 2 mM EDTA and 6 M
urea supplemented with 0.2 mM PMSF, as well as 10 mg/ml
leupeptin and aprotinin. To obtain cell homogenates, samples,
after three freeze–thaw cycles, were twice sonicated in ice for 5 s
and then centrifuged at 14,000  g for 10 min at 4 8C. The
supernatant was then collected. The protein concentration was
determined according to the Bradford method [33].
2.6. Determination of intracellular ROS
Cells were cultured on glass coverslips and loaded with dye by
adding the ROS-sensitive fluorescent probe CM-H2, DCFDA,
dissolved in 0.1% DMSO (2.5mM) and pluronic acid F-127
(0.01%, w/v), to the cell culture media for 10 min at 37 8C. The
cells were fixed in 2.0% buffered paraformaldehyde for 10 min at
room temperature and the DCF fluorescence analysed (at an
excitation wavelength of 488 nm) using a confocal Leica TCS SP5
scanning microscope (Mannheim, Germany) equipped with an
argon laser source for fluorescence measurements. The observa-
tionswere performed by collecting the emitted fluorescencewith a
Leica Plan Apo 63x oil immersion objective. A series of 1.0 mm-
thick optical sections (1024  1024 pixels) of the cells was taken at
intervals of 0.5 mm. A number of optical sections (ranging from 10
to 20) for each examined sample were then projected as a single
composite image by superimposition.
Reactive oxygen species (ROS) generation was also monitored
by flow cytometry. Single-cell suspensions of cells were incubated
with DCFH-DA (1mM) at 37 8C for 15 min and immediately
analysed by flow cytometry.
2.7. Total antioxidant capacity (TAC)
Intracellular TAC, accounting for total hydrophilic ROS
scavengers, was measured in cell lysates by a chemilumines-
cence assay using the photoprotein Pholasin (Abel Antioxidant
Test Kit, Knight Scientific Limited, UK). After washing with PBS,
cells were resuspended in 20 mM Tris–HCl buffer, pH 8.0,
containing 1.0% Triton, 137 mM NaCl, 10% glycerol, 6.0 M urea,
0.1 mM PMSF, 10 mg/ml leupeptin and 10 mg/ml aprotinin prior
to storage at ÿ80 8C until use. Cell plasma membranes were
broken by three freeze-thaw cycles, 5.0 s sonication in ice and
centrifugation at 14,000  g for 10 min at 4.0 8C. Protein content
in the soluble fraction was measured by the method of Bradford.
The results were calculated using an L-ascorbic acid-based
standard curve.
2.8. Evaluation of lipid peroxidation
To assess the rate of lipid peroxidation, isoprostane levels were
measured in cell lysates using the 8-isoprostane EIA kit (Cayman
Chemical Company, Ann Arbor, MI, USA), following the manu-
facturer’s instructions. Lipid peroxidation was also investigated by
confocal scanning microscopy using BODIPY, a fluorescent probe
that is intrinsically lipophilic and thus mimics the properties of
natural lipids [34]. BODIPY 581/591 C11 acts as a fluorescent lipid
peroxidation reporter that shifts its fluorescence from red to green
in the presence of oxidising agents. Briefly, cells were cultured on
glass coverslips and loaded with dye by adding the fluorescent
probe BODIPY, dissolved in 0.1% DMSO (5mMfinal concentration),
to the cell culturemedia for 30 min at 37 8C. The cells were fixed in
2.0% buffered paraformaldehyde for 10 min at room temperature
and the BODIPY fluorescence analysed (at an excitation wave-
length of 581 nm) using a confocal Leica TCS SP5 scanning
microscope (Mannheim, Germany) equipped with an argon laser
source for fluorescence measurements. The observations were
Fig. 1. Direct immunofluorescence: keratinocytes showing a clear-cut positivity for
pan-anti-cytokeratin antibody. Third passage in vitro (150).
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performed by collecting the emitted fluorescence with a Leica Plan
Apo 63x oil immersion objective. A series of 1.0 mm-thick optical
sections (1024  1024 pixels) of the cells was taken at intervals of
0.5 mm. A number of optical sections (ranging from 10 to 20) for
each examined sample were then projected as a single composite
image by superimposition.
Lipid peroxidation was also quantified by flow cytometry.
Single-cell suspensions were washed twice with PBS and
incubated, in the dark, for 30 min at 37 8C with BODIPY 581/591
(2 mM) in DMEM. After labelling, cells were washed and
resuspended in PBS and analysed using a FACSCanto flow
cytometer (Becton-Dickinson, San Jose, CA).
2.9. Mitochondrial activity assay
Mitochondrial activity was assessed by the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay in a 96-well plate [35]. After washing with PBS, 100 ml of
0.5 mg/ml MTT solution in PBS was added to the cell cultures and
the sampleswere incubated for 4.0 h at 37 8C. Finally, 100 ml of cell
lysis buffer (20% SDS, 50% N,N-dimethylformamide, pH 4.7) was
added to each well and the samples were incubated for at least 3 h
at 37 8C in a humidified incubator, before absorbance values of blue
formazan were determined at 590 nm using an ELISA plate reader.
Cell viability was expressed as percent of MTT reduction.
2.10. Mitochondrial permeability
Mitochondrial permeability was measured by calcein fluores-
cence according to the method described by Petronilli et al. [36],
albeit with minor modifications. Briefly, calcein/AM freely enters
the cell and emits fluorescence upon de-esterification. Co-loading
of cells with cobalt chloride quenches the fluorescence in the cell
except in mitochondria—this is because cobalt cannot cross
mitochondrial membranes (living cells). During induction of the
MPT, cobalt can enter the mitochondria and is able to quench
calcein fluorescence (apoptotic cells). Thus, decreased mitochon-
drial calcein fluorescence can be taken as a measure of the extent
of MPT induction. Cells were cultured on glass coverslips and
loaded with dye by adding the fluorescent probes calcein-AM
(3 mM) and cobalt chloride (1 mM) to the cell culture media for
20 min at 37 8C.
Following cobalt quenching, cells were washed with HBSS and
fixed in 2.0% buffered paraformaldehyde for 10 min at room
temperature and the fluorescence analysed (at excitation wave-
lengths of 488 and 543 nm) using a confocal Leica TCS SP5 scanning
microscope (Mannheim, Germany) equipped with an argon laser
source for fluorescence measurements. The observations were
performed by collecting the emitted fluorescence with a Leica Plan
Apo 63x oil immersion objective. A series of 1.0 mm-thick optical
sections (1024  1024 pixels) of the cells was taken at intervals of
0.5 mm. A number of optical sections (ranging from 10 to 20) for
each examined sample were then projected as a single composite
image by superimposition.
Mitochondrial permeability was also quantified by flow
cytometry. Briefly, single-cell suspensions were incubated with
the fluorescent probes calcein-AM (3mM) and cobalt chloride
(1 mM) for 20 min at 37 8C, washed twice with PBS and analysed
using a FACSCanto flow cytometer (Becton-Dickinson, San Jose,
CA).
Fig. 2. A keratinocyte of healthy skin. An ultrastructural picture of a keratinocyte with no modification or alteration of the organelles (EM 12.000). A keratinocyte of
perilesional skin. Most of the mitochondria within the cell show an ultrastructural alteration: a swelling of their membranes (arrowhead) or a rearrangement of the cristae
(EM 12.000). A keratinocyte of lesional skin. The cell shows a rich cytoskeleton with no alterations of the organelles (EM 10.000). A Langerhans cell of healthy skin. A
typical dendritic cell with a polilobulated nucleous and some Birbeck granuleswithin the cytoplasm (arrowhead) (EM12.000). A Langerhans cell of perilesional skin. The cell
shows the characteristic intended nucleous and no organelles alterations: (EM 12.000). A Langerhans cell of lesional skin. The cell showsmany Birbeck granules within the
cytoplasm; somewith the characteristic racket-like shape (arrow) and some otherswithout the terminal gemmation (arrowhead). A largemitochondriawithin the cytoplasm
(asterisk): (EM 12.000). A melanocyte of healthy skin. The cell shows addensed chromatin within the nucleous, a normal distribution of organelles and somemelanosomes
within the cytoplasm: (EM 12.000). A melanocyte of perilesional skin. Many melanosomes are detectable within the cell at various degree of differentiation (arrowhead):
(EM 12.000).
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2.11. Confocal microscope imaging of caspase activity
Cells were cultured on glass coverslips and the culture
media removed and replaced with FAM-FLICATM Caspases 3&7
solution (Caspase 3&7 FLICA kit FAM-DEVD-FMK), FAM-FLICATM
Caspases 8 solution (Caspase 8 FLICA kit FAM-LETD-FMK) and
FAM-FLICATM Caspases 9 solution (Caspase 9 FLICA kit FAM-
LEHD-FMK), Immunochemistry Technologies, LLC, Bloomington,
MN, for 1 h, following the manufacturer’s instructions. Cells
were washed three times with a wash buffer provided with the
kit and fixed in 2.0% buffered paraformaldehyde for 10 min at
room temperature. Fluorescence was detected at an
excitation wavelength of 488 nm using a confocal Leica TCS
SP5 scanning microscope (Mannheim, Germany) equipped
with an argon laser source for fluorescence measurements.
The observations were performed by collecting the
emitted fluorescence with a Leica Plan Apo 63x oil immersion
objective. A series of 1.0 mm-thick optical sections (1024  1024
pixels) of the cells was taken at intervals of 0.5 mm. A number of
optical sections (ranging from 10 to 20) for each examined
sample were then projected as a single composite image by
superimposition.
2.12. Assessment of caspase-3 activity by Western blot
and FACS analysis
To assess the levels of caspase-3 (cleaved form) present in
cell lysates, equal amounts of total homogenate (40 mg) were
diluted in Laemmli sample buffer and boiled at 90 8C for 5 min.
Proteins were separated on 15% SDS-PAGE and were transferred
to PVDF hybond membrane (Millipore Corporation, Billerica,
MA, USA). The membrane was then incubated overnight at 4 8C
with (rabbit) anti caspase-3/CPP32 antibody (Biosource Inter-
national, CA, USA). After washing, the membrane was incubated
with a peroxidase-conjugated secondary antibody for 1 h.
Immunolabelled bands were then detected using a SuperSignal
West Dura (Pierce, Rockford, IL, USA) and quantified using the
image analysis Quantity One software (Bio-Rad Laboratories,
Milano, Italy). Results were expressed as ratios between the
densitometry of the protein of interest and the densitometry of
the loading control, b-actin (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, USA).
Caspase-3 activity was also quantified by flow cytometry.
In brief, single-cell suspensions were incubated with FAM-
FLICATM Caspases 3&7 solution (Caspase 3&7 FLICA kit FAM-
DEVD-FMK) for 1 h at 37 8C, washed twice with PBS and
analysed using a FACSCanto flow cytometer (Becton-Dickinson,
San Jose, CA).
2.13. Mitochondrial membrane potential (Dc)
Mitochondrial membrane potential (Dc) was assessed using
tetramethylrhodamine, methyl ester, and perchlorate (TMRM).
TMRM is a lipophilic potentiometric dye those partitions
between the mitochondria and cytosol in proportion to Dc
by virtue of its positive charge. At low concentrations, the
fluorescence intensity is a simple function of dye concentration,
which is in turn a direct function of mitochondrial potential.
Therefore, the accumulation of dye in mitochondria and the
intensity of the signal is a direct function of mitochondrial
potential. For confocal microscope analysis, cells were cultured
on glass coverslips and loaded with dye by adding the
fluorescent probe TMRM, dissolved in 0.1% DMSO (100 nM final
concentration), to the cell culture media for 20 min at 37 8C. The
cells were fixed in 2.0% buffered paraformaldehyde for 10 min at
room temperature and the TMRM fluorescence analysed (at an
excitation wavelength of 543 nm) using a confocal Leica TCS SP5
scanning microscope (Mannheim, Germany) equipped with an
helium-neon laser source for fluorescence measurements. The
observations were performed by collecting the emitted fluor-
escence with a Leica Plan Apo 63x oil immersion objective. A
series of 1.0 mm-thick optical sections (1024  1024 pixels) of
the cells was taken at intervals of 0.5 mm. A number of optical
sections (ranging from 10 to 20) for each examined sample
were then projected as a single composite image by super-
imposition.
Mitochondrial membrane potential was also quantified by flow
cytometry. Single-cell suspensions were washed twice with PBS
and incubated, in the dark, for 20 min at 37 8C with TMRM
(100 nM) in DMEM. After labelling, cells were washed and
resuspended in PBS and analysed using a FACSCanto flow
cytometer (Becton-Dickinson, San Jose, CA).
2.14. Cell proliferation
Cell proliferation was measured using a fluorometric resazurin
reduction method (CellTiter-Blue, Promega Corp.). Resazurin is a
redox dye commonly used as an indicator of chemical cytotoxicity
in cultured cells [35]. The assay is based on the ability of viable,
metabolically active cells to reduce resazurin to resorufin and
dihydroresorufin, where the rate of dye reduction is directly
proportional to the number of viable cells present. This conversion
is intracellular and is facilitated bymitochondrial, microsomal and
cytosolic oxidoreductases. The resorufin produced as a result of
Fig. 3. (A) Cellular TAC. Total antioxidant capacity, expressed in ascorbate
equivalent units, was measured by a chemiluminescent assay in the cytosolic
fractions of keratinocyte lysates from healthy, perilesional and lesional skin. (B)
Rate of lipid peroxidation, quantified according to cytosolic levels of 8-isoprostanes
(see Section 2). The reported values (means  s.d.) are representative of five
independent experiments carried out in triplicate. *Significant difference (p  0.05) vs.
keratinocytes from healthy skin.
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resazurin bioreduction is measured fluorometrically. Resazurin is
non-toxic to cells and stable in culture medium, allowing
continuous measurement of cell proliferation in vitro as either a
kinetic or endpoint assay.
2.15. Statistical analysis
All data is expressed as mean  S.E.M. Comparisons between
different groups were performed by ANOVA and then by the
Fig. 4.Oxidative stressmarkers: (A) Representative confocal microscope images of lipid peroxidation in keratinocytes loadedwith the fluorescent probe BODIPY, according to
Section 2. (B) Representative confocal microscope images of intracellular ROS production in keratinocytes from healthy, perilesional and lesional skin. Reactive oxygen
species formation was also assessed by FACS (D). (C) Flow cytometry analysis of lipid peroxidation. Keratinocytes from healthy, perilesional and lesional skin were loaded
with fluorescent probe BODIPY and the green signal detected.
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Fig. 5. Mitochondrial activity in keratinocytes from healthy, perilesional and
lesional skin. Mitochondrial activity was checked using the MTT test. Values are
expressed as % vs. keratinocytes from healthy skin. The reported values
(means  s.d.) are representative of five independent experiments, each performed
in triplicate. *Significant difference (p  0.05) vs. keratinocytes from healthy skin.
Fig. 6. Cellular proliferation. Cellular proliferation was measured using a
fluorometric resazurin reduction method, according to Section 2. The reported
values (means  s.d.) are representative of four independent experiments, each
performed in triplicate. *Significant difference (p  0.05) vs. keratinocytes from
healthy skin.
Fig. 7. (A) Representative confocal microscope images showing the mitochondrial permeability transition pore opening in keratinocytes from perilesional skin of vitiligo
patients. Mitochondrial fluorescence is evident in keratinocytes from healthy and lesional skin but not in keratinocytes from perilesional skin. Mitochondrial fluorescence
was also assessed by FACS analysis (C). (B) Confocal analysis ofmitochondrial depolarisation in keratinocytes from perilesional skin. Mitochondrial membrane potential (Dc)
was assessed using tetramethylrhodamine, methyl ester, and perchlorate (TMRM). TMRM fluorescence was also detected by FACS analysis (D).
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Bonferroni t-test. A p value of <0.05 was accepted as statistically
significant.
3. Results
3.1. Ultrastructural analysis
3.1.1. Lesional skin
The basal membrane appears well preserved but slightly
flattened, with anchoring fibrils maintained in the correct position.
Melanocytes are not detected in any of the observed fields.
Membrane fragments with cytoplasmic density similar to that of
the melanocytary cytoplasm are only observed in two patients.
Keratinocytes show no cytoskeletal alterations or substantial
reorganisation of intracytoplasmatic organelles, except in those
areas characterised by a greater electron density alternated with
lighter patches, which are probably vacuoles.
Langerhans cells, located at basal level (Fig. 2), display an
indented nucleus, a rough endoplasmic reticulum (RER) and awell-
developed Golgi apparatus in the cytoplasm. Typical Birbeck
granules (arrow and arrowheads) can be observed inside these
cells. The micrograph also shows a remarkable number of larger
mitochondria, compared to those present in the Langerhans cells of
the normal skin sample from the same patient (asterisk). An
additional population of ‘‘clear cells’’, characterised by the
presence of an indented nucleus and many RER cisternae, lack
Birbeck granules: nevertheless, they are rich in structures, which
are present along the concave cisternae of the Golgi apparatus, that
have the same electron density as Birbeck granules. These features
confer the immunophenotype of immature dendritic cells, or less
differentiated Langerhans cells, to these cells.
3.1.2. Perilesional skin
Despite some focal interruptions, the basal membrane appears
well developed,with fully organised anchoring fibrils.Melanocytes
are well preserved (Fig. 2) and rich in organelles, such as RER, Golgi
apparatus and intermediate filaments. Mitochondria appear very
large (arrow), reflecting ultrastructural alterations of the cristae.
Most melanocytes show well-preserved melanosomes. These
are not detected at the earlier phase of differentiation; on the
contrary, melanosomes at the second, third and fourth phases of
differentiation are observed (arrowheads). Some of these melano-
somes are round in shape and do not show substantial
ultrastructural modifications.
Langerhans cells, which have a tendency to localise in the
suprabasal level, are particularly abundant. They have a typical
ultrastructure, with Birbeck granules present in most cells, though
several cells with a more immature phenotype can be observed.
Keratinocytes (Fig. 2) show partial vacuolisation and the
presence of granular cytosolic material. The same material is also
present in the extracellular environment between melanocytes
and keratinocytes, as well as between keratinocytes. Most of the
mitochondria have swollen membranes (arrow) and rearranged
cristae (arrowhead), aswell as a swollenmatrix and perimembrane
space (asterisk).
3.1.3. Healthy skin
The basal membrane shows well-preserved anchoring fibrils
and appears very well developed, with no signs of degeneration.
Melanocytes appear normal in number and size and are
characterisedbya largenumberofmelanosomes inalldifferentiative
phases,astructuredroughendoplasmicreticulumandlargebutwell-
preserved mitochondria. In some melanocytes, focal degenerative
signs, such as intracellular edema and vacuoles, can be detected.
Langerhans cells, though lacking dendritic structures, appear
normal in number and dimension. These cells show the
immunophenotype typical of an intermediate differentiation
stage, as they all contain Birbeck granules.
Keratinocytes have the ultrastructural features of healthy cells
and only in two cases is there reduced distribution of the
cytoskeleton, when signs indicating cellular suffering and/or
degeneration are absent.
3.1.4. Biochemical assays
As a first attempt to evaluate the extent of oxidative damage in
the cultured cells, isoprostane levels and the fluorescence of the
lipophilic probe BODIPY were assessed. Fig. 3B shows that
isoprostane levels are significantly increased in keratinocytes
from perilesional skin, but not in cells from normal and lesional
skin. Similarly, the shift in BODIPY fluorescence is only present in
cells from perilesional skin (Fig. 4A and C) as shown by confocal
microscopy and FACS analysis.
In accordance with these findings, ROS production has been
found to be strongly enhanced in perilesional skin (Fig. 4B and D).
There is no significant evidence for the presence of ROS in healthy
and lesional skin samples.
Total antioxidant capacity (Fig. 3A), being unvaried in lesional
skin compared to healthy skin, is clearly reduced in perilesional
skin. The keratinocytes from perilesional skin show a marked
reduction in mitochondrial activity with respect to healthy and
lesional cells, as determined by the MTT reduction test (Fig. 5).
Cell proliferation rate, which was evaluated by the resazurin
reduction method assay, revealed a strong increase in cell number
in perilesional skin (Fig. 6).
Fig. 8. Western blot analysis of caspase-3 activity. All signals were quantified by
densitometric analysis and are expressed as a ratio of NF-kB densitometry of b-
actin (loading control) densitometry. Caspase-3 activity was also assessed FACS
analysis. Mitochondrial membrane depolarisation in keratinocytes from
perilesional skin is accompanied by apoptotic events. No signs of apoptosis are
present in healthy and lesional skin.
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Cell viability, whichwas assessed by theMTT assay, revealed, in
perilesional skin, a decrease in mitochondrial activity that was not
present in lesional and healthy skin. Confocal and FACSmicroscopy
analysis indicated, in perilesional skin, mitochondrial permeability
transition pore opening (Fig. 7A and C) and mitochondrial
membrane depolarisation (Fig. 7B and D). These changes were
not evident in lesional and healthy skin.
Caspase-3 activity, whichwas assessed byWestern blotting and
FACS analysis, indicated that mitochondrial membrane depolar-
isation in keratinocytes from perilesional skin is accompanied by
apoptotic events (Fig. 8). No signs of apoptosis are present in
healthy and lesional skin.
Data concerning the apoptotic markers show that caspase-3,
caspase-8 and caspase-9 activities were nearly absent in healthy
skin, while they were strongly enhanced in perilesional skin
(Fig. 9).
4. Discussion
An interesting finding arising from this work is the morpho-
logical alterations of mitochondria in keratinocytes from perile-
sional skin and the increased number of Langerhans cells, in
varying differentiative phases, in lesional skin. In keratinocytes,
mitochondria appear swollen and lack a normal and organised
ultrastructure of internal and external membrane systems;
remarkably, they show a relevant subversion of the mitochondrial
cristae. Mitochondrial activity plays a crucial role in normal cell
function. Indeed, the mitochondrial respiratory chain and oxida-
tive phosphorylation generate energy, in the form of ATP
molecules that are needed for the cell’s main activities, such as
cell differentiation, proliferation and mitosis. Several studies have
focussed their attention on the changes in mitochondrial
membrane potential, particularly for its possible involvement in
the induction of apoptotic mechanisms. One theory is that a
collapse in the mitochondrial transmembrane electrical potential
would represent an early event and possible cause of programmed
cell death [37].
In our study, the mitochondrial alterations observed in
perilesional keratinocytes appear to be very similar to those
described by Sun et al. in the same cell types during apoptosis [38].
In order to explain the origin of these alterations and to detect
additional signs of apoptosis in keratinocytes, we performed a
number of biochemical assays in the cultured cells. The results of
these measurements show that the ultrastructural alterations
found in keratinocytes from perilesional skin are directly related to
an impaired mitochondrial activity, with evidence of membrane
depolarisation. The mitochondrial damage is associated with an
increase in ROS production and, hence, oxidative stress, which is
confirmed by the presence of lipoperoxidation markers (BODIPY
fluorescence shift and isoprostane levels) and by the concomitant
decrease in total antioxidant capacity. At a perilesional level, a
marked activation of caspase-3, caspase-8 and caspase-9 – three
strong indicators of the apoptotic process – was also observed. In
light of previous studies [10,39–41], which report a role for
Fig. 9. Confocal evaluation of caspase activation. The activation of the apoptotic process was assessed by measuring the change in fluorescence in caspase-3, caspase-8 and
caspase-9 activity. For details, see Section 2.
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oxidative stress in lesional vitiligo skin, our data suggest a possible
involvement of perilesional keratinocytes in (the impairment of)
damaging the epidermis, as a result of increased oxidative stress
and a reduction in antioxidant levels.
According to the current view of the apoptotic pathway, it is
accepted that initial cell stress, caused by an overproduction of free
radicals in the epidermis, activates the pro-apoptotic members of
the bcl-2 family. These proteins are localised in the cytosol, where
they act as probes for cell damage or stress; once activated, they
relocate to the mitochondrial surface, thereby leading to the
formation of transmembrane pores (Permeability Transition Pore,
or PT pore). These pores, which are responsible for mitochondrial
membrane depolarisation and for the reduction of mitochondrial
activity, promote the release of many pro-apoptotic proteins, such
as cytochrome c and various molecules from the intermembrane
space [42]. Once released into the cytosol, these proteins promote
the activation of caspase-9, the initiator caspase [43,44], which can
in turn activate the effector caspases, such as caspase-3 and
caspase-6. The latter are responsible for the cleavage of key cellular
proteins, such as cytoskeletal proteins, leading to the typical
morphological changes observed in cells undergoing apoptosis
[45].
Our results also clearly indicate an increase in caspase-8
activity. This finding is in agreement with a recent report [46]
describing significantly higher levels of TNF-alpha and FasL in the
depigmented epidermis, which indicates a role for these factors in
increasing apoptosis. In this study, PTEN (phosphatase and tension
homologue), which could inhibit the phosphatidylinositol 3-
kinase/protein kinase B (PI3K/Akt) signalling pathway was
significantly higher in the depigmented epidermis, implying that
vitiliginous keratinocytes may be more susceptible to TNF-alpha-
mediated apoptosis through impaired Akt and NF-kB activation.
As reported by Lee et al., apoptotic keratinocytes appear to
cause a decrease in SCF (Stem Cell Factor) synthesis. In these in
vitro studies, apoptotic keratinocytes produce lower levels of SCF
mRNA and SCF proteins compared to normal keratinocytes. SCF
plays an important role inmelanocyte survival and proliferation, as
indicated by the induction of apoptosis inmelanocyteswhen SCF is
removed. These results could also apply to in vivo findings.
Furthermore, keratinocyte apoptosis induces a decrease in the
synthesis of other melanocyte growth factors, such as bFGF, where
a loss of these melanocyte survival factors causes melanocyte
apoptosis, resulting in their disappearance from the lesions of
vitiligo patients [47–50].
Our study highlights, for the first time, that the biochemical and
ultrastructural alterations were primarily observed in perilesional
skin, rather than in lesional or healthy skin. This leads us to suggest
that perilesional skin represents the substrate where melanocyte
death is initiated. The extent to which these cells are destroyed
depends on the evolution of the disease and on the ‘‘noxa’’, which
stimulates the damage. It is possible that the alteration of
mitochondrial functionality and, perhaps, an apoptotic induction
is responsible for the observed melanocytic damage. The endpoint
of this biological event might cause the death of melanocytes in
lesional skin, with an increase in Langerhans cells possibly due
either to a subversion of the normal epidermic reorganisation or,
more likely, a stimulation by local biohumoral factors (as proved
by the increased number of Langerhans cells displaying an
immature phenotype).
Besides considering the achromic patch as the terminal event of
a chain of biological processes that take place in perilesional skin,
our data suggests that keratinocytes play a very important role in
vitiligo development. Keratinocytes should no longer be consid-
ered as innocent bystanders of immunological events but as real,
integrative components of the melanic unit formed by melano-
cytes, keratinocytes and Langerhans cells in the epidermis.
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